Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 23INDUSTRY 3NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Pain Related to Cancer 1Opioid-Related Disorders 1Lymphoma, Follicular 1Cancer Pain 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Methadone × Clear all
NCT01793480 2024-10-31

EQUIMETH2

RECORDATI GROUP

Phase 3 Completed
146 enrolled

Pain Related to Cancer

NCT05265442 2024-10-31

DUNE

RECORDATI GROUP

Completed
136 enrolled

Cancer Pain

NCT05251376 2023-01-19

Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy

Lyndra Inc.

Phase 1 Withdrawn
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡